bpc-157 case report human and the Difference Between an Evidence Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded BPC 157 Therapy and the
Description
Enhanced with the substitution of an Arginine for the third position of its amino acid sequence and an extension peptide at the N-terminus, IGF-1 LR3 is designed to boost the biological activity of the IGF hormone

He was told he could not have more injections as they were at risk of being criticised by specialists and even if they could give him the injections, there were not enough appointment times available to administer them

And without adequate protein to support muscle synthesis, more of the GH-mobilized energy may be wasted

Doesn't allow enough time for adaptation and diminishes the magnitude of response when you resume
